Livio Trentin mostly deals with Immunology, Bronchoalveolar lavage, Cancer research, Chronic lymphocytic leukemia and Internal medicine. His study focuses on the intersection of Immunology and fields such as Lung with connections in the field of Cellular immunity and Cytokine. His biological study spans a wide range of topics, including T lymphocyte, Sarcoidosis, Pathology, Chemokine and CXCR3.
His Cancer research research incorporates themes from Mutation, Cell culture, CD70 and CD30. His Chronic lymphocytic leukemia research integrates issues from Therapeutic strategy, Hairy cell leukemia and Telomerase, Telomerase reverse transcriptase. The study incorporates disciplines such as Gastroenterology, Endocrinology, Surgery and Immunoglobulin heavy chain in addition to Internal medicine.
His scientific interests lie mostly in Immunology, Internal medicine, Chronic lymphocytic leukemia, Cancer research and Oncology. His Immunology research includes elements of Cytotoxic T cell and Bronchoalveolar lavage, Lung. His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Endocrinology.
His Endocrinology research focuses on subjects like Receptor, which are linked to Cytokine. His Chronic lymphocytic leukemia study combines topics in areas such as Hairy cell leukemia, Antibody and Fludarabine. His work deals with themes such as Kinase, Protein kinase A, Apoptosis, LYN and Signal transduction, which intersect with Cancer research.
The scientist’s investigation covers issues in Internal medicine, Chronic lymphocytic leukemia, Ibrutinib, Oncology and Cancer research. His work investigates the relationship between Internal medicine and topics such as Gastroenterology that intersect with problems in Chemotherapy and BEACOPP. As part of his Leukemia and Immunology and Chronic lymphocytic leukemia studies, Livio Trentin is studying Chronic lymphocytic leukemia.
His study connects Polyneuropathy and Immunology. His Oncology study incorporates themes from Complex Karyotype, Clinical trial, Retrospective cohort study and MEDLINE. His Cancer research research includes themes of Apoptosis, Mantle cell lymphoma, Chemokine, Signal transduction and Kinase.
His primary areas of investigation include Chronic lymphocytic leukemia, Internal medicine, Ibrutinib, Oncology and Cancer research. The various areas that Livio Trentin examines in his Chronic lymphocytic leukemia study include Gastroenterology, Antibody, Rituximab and Bone marrow. His Antibody study contributes to a more complete understanding of Immunology.
Borrowing concepts from Antibody titer, he weaves in ideas under Immunology. His Cancer research research is multidisciplinary, relying on both Heat shock protein, Hsp70, HSF1, Chemotaxis and PI3K/AKT/mTOR pathway. The concepts of his Leukemia study are interwoven with issues in Survival rate, Hematology and Retrospective cohort study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
BRAF mutations in hairy-cell leukemia
Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes.
The New England Journal of Medicine (2011)
Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
Andrea Gallamini;Martin Hutchings;Luigi Rigacci;Lena Specht.
Journal of Clinical Oncology (2007)
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease
Andrea Gallamini;Luigi Rigacci;Francesco Merli;Luca Nassi.
Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis
Antonella Contri;Anna Maria Brunati;Livio Trentin;Anna Cabrelle.
Journal of Clinical Investigation (2005)
The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale.
Andrea Gallamini;Sally F. Barrington;Alberto Biggi;Stephane Chauvie.
Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection
Carlo Agostini;Fiorella Calabrese;Federico Rea;Monica Facco.
American Journal of Pathology (2001)
Involvement of the IP-10 Chemokine in Sarcoid Granulomatous Reactions
Carlo Agostini;Marco Cassatella;Renato Zambello;Livio Trentin.
Journal of Immunology (1998)
ROLE OF IL-15, IL-2 AND THEIR RECEPTORS IN THE DEVELOPMENT OF T CELL ALVEOLITIS IN PULMONARY SARCOIDOSIS
C Agostini;L Trentin;M Facco;R Sancetta.
Journal of Immunology (1996)
The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions
G. Semenzato;F. Pandolfi;T. Chisesi;G. De Rossi.
THE CHEMOKINE RECEPTOR CXCR3 IS EXPRESSED ON MALIGNANT B CELLS AND MEDIATES CHEMOTAXIS
Livio Trentin;Carlo Agostini;Monica Facco;Francesco Piazza.
Journal of Clinical Investigation (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: